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The regulation of glycogen metabolism in mammalian skeletal muscle represents one of the most complex of all known systems of metabolic control, and many of the discoveries made with this system have subsequently proved to have a more general significance. These include: (a) the discovery that AMP is a specific activator of phosphorylase, the first described example of enzyme activation by an allosteric effector (Cori et al., 1938) ; (6) the discovery that phosphorylase is also regulated through a phosphorylationdephosphorylation mechanism, catalysed by a phosphorylase kinase and phosphorylase phosphatase, the first example of enzyme regulation by reversible covalent modification (Krebs & Fischer, 1956) ; (c) the discovery of cyclic AMP and cyclic AMP-dependent protein kinase and their role in the hormonal control of glycogen metabolism (Rall etal., 1957; Walsh et al., 1971) , which signalled an explosive increase in interest in the molecular basis of hormone action.
Structural features oJ'glycogen-metuholizi~I~ erizymes
It is now known that not only glycogen phosphorylase but also phosphorylase kinase and glycogen synthetase are subject to control by phosphorylation and dephosphorylation mechanisms. The activation of phosphorylase kinase and inactivation of glycogen synthetase are both catalysed by a cyclic AMP-dependent protein kinase, which links breakdown and synthesis of glycogen to hormonal regulation by adrenaline (Soderling er a/., 1970) . Phosphorylase kinase also catalyses the phosphorylation and activation of itself in vitro, a reaction stimulated by Ca2+ but not cyclic AMP (Walsh et nl., 1971) , but the physiological significance of this autophosphorylation reaction is not yet clear. Some Table 1 . Some structural and regulatory properties of the enzymes of glycogen metabolism from rabbit skeletal muscle
All experiments were carried out in 50 m-sodium glycerophosphate-1 mM-EDTA-1 m~-dithiothreitol, pH 7.0.
Property Absorbance index E&
Absorbance ratio ELso/E2L~ t Calculated from amino acid composition data.
: Assumed.
9:
Above 4-5 mg/ml association to higher-molecular-weight species occurs.
, Assuming 500ml of intracellular water/kg of muscle.
I-. , 1975) . A striking feature of these enzymes is their constituent subunits, which are among the longest of all known polypeptide chains. With debranching enzyme this probably reflects the presence of two distinct enzyme activities, and therefore presumably two distinct active centres on a single polypeptide chain (Taylor et al., 1979, namely the oligo-1 ,Cglucan transferase and amylo-l,6-glucosidase activities required to debranch a glycogen phosphorylase limit dextrin (Brown & Illingworth, 1962) . With the other three enzymes the large subunits may reflect a need to accommodate many independent sites for binding substrates, cofactors and regulatory molecules, several of which are macromolecular. Phosphorylase possesses binding sites for its substrates glycogen and Pi, for pyridoxal phosphate essential to activity, for the allosteric activator AMP and inhibitors glucose 6-phosphate and ATP, and for interaction with phosphorylase kinase and phosphorylase phosphatase (for a review see Fischer et al., 1971) . Likewise phosphorylase kinase must possess sites for interaction with the substrates phosphorylase b and ATP-Mg2+, for the Ca2+ essential for activity, for interaction with cyclic AMP-dependent protein kinase and, as described below, for two distinct phosphorylase kinase phosphatases, and also sites for interaction with glycogen (for a review see Cohen, 19736) . Glycogen synthetase interacts with UDPglucose and glycogen, with the allosteric activator glucose 6-phosphate and inhibitor Pi (Piras et al., 1968) , and with cyclic AMP-dependent protein kinase and glycogen synthetase phosphatase. It additionally interacts with a recently discovered glycogen synthetase kinase 2, which is discussed below.
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Hormonal control of phosphorylase kinase activity A considerable effort has been made in this laboratory over the past few years to understand this reaction (Scheme l), which is now known to be more complex than just the 'simple' activation and inactivation of the enzyme (Cohen, 1973a Antoniw & Cohen, 1975) . Cyclic AMP-dependent protein kinase not only activates phosphorylase kinase by catalysing the rapid phosphorylation of one site on the B-subunit of the enzyme, but also, through the slower phosphorylation of a further site on the a-subunit, it determines the time at which dephosphorylation of the 8-subunit and hence inactivation of the enzyme can commence. Phosphorylation of the a-subunit appears to alter the conformation of phosphorylase kinase in such a way that the enzyme phosphorylated in both the a-and /?-subunits is a %fold better substrate for /3-phosphorylase kinase phosphatase than the enzyme labelled in the B-subunit alone. The lag period that must occur before dephosphorylation and phosphorylation compete undoubtedly facilitates phosphorylase a formation and glycogenolysis after the release of adrenaline. When the phosphorylation of the a-and /%subunits is complete, whether or not 8-subunit dephosphorylation and inactivation occurs, depends on the relative activities of two distinct phosphorylase kinase phosphatases, specific for the a-subunit and B-subunit phosphorylation sites respectively, which have now been resolved (Antoniw & Cohen, 1975) . B-phosphorylase kinase phosphatase is the enzyme that reverses hormonal activation, whereas a-phosphorylase kinase phosphatase inhibits the reversal of hormonal activation. The two phosphatases therefore have opposing functions, and are likely to be under opposite forms of control. Phosphorylation of the a-subunit does not prevent the rephosphorylation of the 8-subunit. The identification of the new regulatory enzyme, a-phosphorylase kinase phosphatase, suggests that the regulation of the inactivation of hormonal responses may be as sophisticated as the mechanisms that initiate those responses. These discoveries have also raised interest in the possibility that other enzymes might be regulated by multivalent phosphorylation.
Identities between the protein phosphatases ofglycogen metabolism
The separation of two distinct phosphorylase kinase phosphatases raised the question of the possible relationship of these activities to the other protein phosphatases of glycogen metabolism. a-and B-Phosphorylase kinase phosphatases co-purify through a 100-fold purification from muscle extracts, but can be separated by gel filtration on Sephadex (3-200. After this step, a-phosphorylase kinase phosphatase (apparent mol.wt. about 125 OOO) is purified 1400-fold and 8-phosphorylase kinase phosphatase (apparent mol.wt. about 80000) 800-fold. The degree of cross-contamination is no more than 10%. By using the same purification method, phosphorylase phosphatase and glycogen synthetase phosphatase have been found to co-purify with 8-phosphorylase kinase phosphatase (Cohen, et al., 19756,~) . The final preparation, though 800-fold purified, is not homogeneous, and a conclusive statement with regard to the identity of the proteins carrying these three activities cannot therefore be made. Nevertheless the results to date suggest that this will prove to be so, and that a single protein phosphatase catalyses all reactions that inhibit glycogenolysis or activate glycogen synthesis. a-Phosphorylase kinase phosphatase appears to be a distinct enzyme. The interrelationship between the various kinase and phosphatase enzymes is summarized in Scheme 2. The results are in agreement with those of Zieve & Glinsmann (1973) , who reported that the phosphatases that activated glycogen synthetase and inhibited phosphorylase kinase activity co-purified extensively, and also with those of Killilea et al.
(1975), who found homogeneous phosphorylase phosphatase from rabbit liver to be capable of dephosphorylating glycogen synthetase.
Structirre of glycogen synthetase
This is a relatively poorly characterized enzyme with regard to both structure and regulation. In this laboratory highly purified glycogen synthetase a shows one major protein staining component (a) (mol.wt. 88000) and a faint minor component (8) (mol. wt. 44000) on sodium dodecyl sulphate-polyacrylamide-gel electrophoresis. Only the a-component is phosphorylated during the conversion into the b form catalysed by cyclic AMP-dependent protein kinase. Preliminary measurements of the molecular weight by high-speed sedimentation equilibrium have given values close to 400000 or Scheme 2. Interrelationship of' the protein kinases and protein p . .xphatases of gI.vcogen metabolism Key: PhK, phosphorylase kinase; Ph, phosphorylase; GS, glycogen synthetase; PrK, protein kinase ; PrP, protein phosphatase, CAMP, cyclic AMP; 6 , inactive enzyme form; a, active form. Phosphorylase b has very similar activity to phosphorylase a in the presence of AMP, glycogen synthetase b has very similar activity to glycogen synthetase a in the presence of glucose 6-phosphate, and phosphorylase kinase b has very similar activity to phosphorylase kinasea at pH 8.2 (but not at physiological pH of 6.8).
4.55 x 88000. Native glycogen synthetase therefore contains four a-subunits. The inexact subunit stoicheiometry may be due to (a) a small error in the measurement of the molecular weight of the native enzyme or its subunit, (b) association of the glycogen synthetase tetramer to higher-molecular-weight polymers or (c) the ,!?-component possibly being a subunit of a glycogen synthetase complex with the structure The ,!?-component co-purifies exactly with glycogen synthetase activity across the final Sepharose 4B column, suggesting that it is not an impurity. However, it might only represent a fragment of the 88 000-dalton component derived by trace proteolysis during the preparation. Further experiments are necessary to distinguish between these possibilities.
Regulation of glycogen synthesi.7 by insulin
The most important unsolved problem in glycogen metabolism concerns the mechanism of action of insulin. insulin not only stimulates glucose transport into muscle, but directs the incorporation of that glucose into glycogen. insulin increases the proportion of glycogen synthetase in the active dephosphorylated a form, and this is thought to be responsible for the increased deposition of glycogen (Villar-Palasi & Larner, 1960) . The effect occurs in the perfused diaphragm in the absence of glucose, indicating that it is not dependent o n increased glucose transport into muscle stimulated by insulin (Danforth, 1965) . The amount of glycogen synthetase a at any instant is presumably a balance between the activity of cyclic AMP-dependent protein kinase and protein phosphatase (Scheme 2). Therefore if these are the only two enzymes that can interconvert glycogen synthetases a and b there are three possible levels at which insulin could act: (1) inhibition of cyclic AMP-dependent protein kinase; (2) activation of protein phosphatase; (3) alteration of glycogen synthetase itself so that it becomes a poorer substrate for the kinase, a better substrate for the phosphatase, or both.
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Insulin does not decrease cyclic AMP concentrations i n muscle (Craig e t a / . , 1969) , and an increase in glycogen synthetase a is therefore unlikely to result from inactivation of cyclic AMP-dependent protein kinase due to decreased cyclic AMP. Further, if insulin promotes inhibition of cyclic AMP-dependent protein kinase or activation of protein phosphatase, the amount of phosphorylase a would be expected to change, which is not observed (Craig et al., 1969) . This suggests that the effect of insulin may be specific t o glycogen synthetase, and that the molecular basis of the effect may lie in the third possibility mentioned above. The discovery of a second glycogen synthetase kinase, termed glycogen synthetase kinase 2 (Nimmo & Cohen, 1974) , has suggested a new hypothesis for such a mechanism. Glycogen synthetase kinase 2 can be distinguished from cyclic AMP-dependent protein kinase by several criteria. It is not activated by cyclic A M P or inhibited by the specific inhibitor protein of cyclic AMP-dependent protein kinase. It has a different nucleoside triphosphate specificity, it phosphorylates a different site on glycogen synthetase and it does not convert glycogen synthetase a into glycogen synthetase b. The stoicheiometry of phosphate incorporation indicates that glycogen synthetase kinases 1 and 2 each catalyse the phosphorylation of a single site on glycogen synthetase per 88000 daltons. Preliminary findings indicate that glycogen synthetase kinase 2-catalysed phosphorylation increases the K, of glycogen synthetase b for glucose 6-phosphate and influences the rate of interconversion of glycogen synthetases a and b catalysed by glycogen synthetase kinase l and protein phosphatase, so that formation of glycogen synthetase b is favoured. The increase in glycogen synthetase a and glycogen deposition stimulated by insulin could therefore stem from a n inhibition of glycogen synthetase kinase 2 activity.
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